Researchers at CAMO-Net India, based at the Postgraduate Institute of Medical Education and Research (PGIMER) in Chandigarh, have established a new liquid chromatography–mass spectrometry (LC-MS) facility, marking an important step in strengthening local capacity for bioanalytical research and therapeutic drug monitoring.
The laboratory focuses on dose optimisation and pharmacokinetic studies of antimicrobial medicines and has already standardised and validated analytical methods for a range of drugs, including antifungals, first-line tuberculosis treatments and antibiotics. The new facility will enable the team to expand these capabilities independently and further support patient care through therapeutic drug monitoring services.
The development of in-country analytical infrastructure is an important part of CAMO-Net’s commitment to building sustainable research capacity and supporting locally led innovation. The facility will also strengthen opportunities for collaboration and knowledge exchange across the network.
Tania Sidana, CAMO-Net India Knowledge Mobilisation Fellow, said:
“Establishing our own LC-MS facility represents a significant milestone for the team. It gives us the ability to undertake high-quality bioanalytical research locally and strengthens our capacity to generate evidence that can support dose optimisation and improve patient care. We are excited about the opportunities this creates for future collaboration and continued growth.”
By investing in local infrastructure and expertise, CAMO-Net aims to support long-term, sustainable approaches to addressing antimicrobial resistance while enabling researchers to generate context-specific evidence where it is needed most.
